Related Experiment Video
Updated: Jul 15, 2026

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
Published on: November 27, 2019
[Prognosis factors in acute hepatic insufficiency]
Carla Bustíos1, Rossana Román, Milagros Dávalos
1Unidad de Hígado, Departamento del Aparato Digestivo, Hospital Nacional Edgardo Rebagliati Martins-EsSALUD.
Introduction:
Acute Hepatic Insufficiency (AHI) is a rare syndrome but has a high mortality rate. The purpose of this study was to determine the clinico-epidemiological characteristics of AHI.
Materials And Methods:
Open study, prospective, descriptive of patients diagnosed with AHI in the Liver Unit of the Edgardo Rebagliati Martins State Hospital (HNERM) from February 1999 until January 2003.
Results:
Fifteen (15) cases were studied. The average age was 63 (30-81), the M-F ratio was 2/1. The diagnosis was viral Hepatitis B (53.3%), toxic idiosyncratic reactions (20%), undetermined (20%) and Hepatitis A (6.7%). At the time of diagnosis 80% had Grade I encephalopathy and 20% Grade III encephalopathy; 13.3% did not have ascites and 86.7% had mild-moderate ascites; 53.3% had a history of chronic illness (diabetes, chronic renal insufficiency, cardiopathy and others). Average laboratory values were: albumin 2.5 gr./dl, bilirubin 25.9 mg/dl, prothrombin time 29 and Factor V 40.7%. The most frequent complications were sepsis and cerebral oedema. Global mortality was 80%. The average survival time was 16.6 days.
Conclusions:
In most cases the patients were over 60 years of age. The main cause of AHI was viral Hepatitis B, a disease which can be prevented with active immunisation. Infection and cerebral oedema were common causes of death. AHI, although rare, is a rapidly degenerative and fatal condition.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Hepatic Encephalopathy
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
